BioCentury
ARTICLE | Finance

Cydan's orphanage

How Cydan aims to launch 5 rare disease companies with backing from NEA, Pfizer

April 15, 2013 7:00 AM UTC

Newco Cydan LLC is entering the rare disease space with the aim of launching five companies over the next four years around assets sourced from academia, not-for-profits and industry that it will de-risk and then spin out or potentially partner or out-license.

The company debuted last week with $16 million in a venture round co-led by New Enterprise Associates and Pfizer Venture Investments. Alexandria Real Estate Equities Inc. also participated...